A Public Resource Compiled by the

Canada: Gene Drives

Print Friendly, PDF & Email
Canada Flag

Lightly Regulated

Gene drives, when developed, would be included in Canada's regulation of novel traits.

Worldwide, gene drive regulations are in flux. Gene drives are being developed using transgenic technology (GMOs) that contain foreign genes, as well as gene editing, including CRISPR (synthetic gene drives), which do not, complicating regulatory oversight as gene editing and GMOs are often regulated differently.

There are no Canadian regulations specifically regarding gene drives. Environment Canada regulates animals developed with biotechnology and the Canadian Environmental Protection Act of 1999 requires environmental and human risk assessments during the development of these animals. Any gene drives developed would be regulated through Canada’s regulation of any products that contain novel traits, regardless of the process (e.g. transgenesis or gene editing) used to develop the product.

Two other organizations would likely be involved if gene drive regulations are developed: Environment and Climate Change Canada (ECCC) is legally mandated to govern genetic technology in animals for research and release; Pest Management Regulatory Agency of Health Canada would have jurisdiction of any organisms with gene drives if they were to be used for pest control.

Products/Research

None

Regulatory Timeline

1999: Canada releases the Canadian Environmental Protection Act to regulate animals developed with biotechnology.

NGO Reaction

Gene drives face fierce opposition from certain environmental advocacy groups, which claim that modified creatures might spread across borders and adversely impact the environment in unseen ways—claims most scientists say are overblown. The Canadian-based ETC Group, the Canadian Biotechnology Action Network (CBAN) and more than 200 global anti-GMO activists and NGOs published an open letter in 2016 opposing gene drives and called for a global moratorium. During the 2016 World Conservation Congress, a select group of NGOs, environmental activists and some scientists voted to adopt a moratorium on supporting research into gene drives. The moratorium call was rejected at the 2016 United Nations Convention on Biodiversity (CBD). Counter NGO groups, including Target Malaria, Island Conservation and Genetic Biocontrol of Invasive Rodents Program, have adopted the opposite position, stating that “gene drive is vital to the future of restoration and critical in preventing extinctions”.

Additional Resources

Click on a country (eg. Brazil, US) or region (eg. European Union) below to find which gene drive products and processes are approved or in development and their regulatory status.

Globe Map

European Union

European Union

Brazil

Brazil

New Zealand

New Zealand

United States

United States

Australia

Australia

Canada

Canada

China

China

United Kingdom

United Kingdom

Israel

Israel

Argentina

Argentina

Japan

Japan

Mexico

Mexico

Russia

Russia

Chile

Chile

Uruguay

Uruguay

Paraguay

Paraguay

India

India

Africa

Africa

Ukraine

Ukraine

Southeast Asia

Southeast Asia

Central America

Central America

Colombia

Colombia

Norway

Norway

Ecuador

Ecuador

Africa

Argentina

Australia

Brazil

Canada

Central America

Chile

China

Colombia

Ecuador

European Union

India

Israel

Japan

Mexico

New Zealand

Norway

Paraguay

Russia

Southeast Asia

Ukraine

United Kingdom

United States

Uruguay

Gene Drive Index
Compare Regulatory Restrictions Country-to-Country

Gene editing regulations worldwide are evolving. The Gene Editing Index ratings below represent the current status of gene editing regulations and will be updated as new regulations are passed.

Colors and ratings guide
 

Regulation StatusRating
Determined: No Unique Regulations*10
Lightly Regulated8
Proposed: No Unique Regulations†6
Ongoing Research, Regulations In Development5
Highly Regulated4
Mostly Prohibited2
Limited Research, No Clear Regulations1
Prohibited0
Lightly Regulated: Gene drives regulated through existing biotechnology laws.
*Determined: No Unique Regulations: Gene and stem cell therapies regulated as phamaceuticals with no additional restrictions.

†Proposed: No Unique Regulations: Decrees under consideration for gene and stem cell therapies that would not require unique regulations beyond current restrictions on pharmaceuticals.

Gene Drives:
Genetic engineering technology used to transmit a characteristic throughout a wild population. For example, it can be used to develop mosquitoes that only have female offspring. If released into the wild, these mosquitoes would breed with wild malaria-carrying mosquitoes and over time would eliminate the population. Scientists are interested in using this technology to help eradicate disease-carrying insects and control invasive species, but questions about how gene drives will be directed and controlled are still being fleshed out.

Rating by Country / Region
Click each column header and arrow to sort the countries / regions

Swipe right/left if all columns aren't visible

Country / RegionGene DrivesGene Drive Rating
Japan11
Brazil88
Canada88
Russia11
Argentina11
Israel11
Australia44
China11
US44
Chile11
New Zealand44
Ukraine11
Central America11
Paraguay11
Uruguay11
India11
UK22
Mexico11
EU22
Share via

Gene editing is a set of techniques that can be used to precisely modify the DNA of almost any organism. It is being used for applications in human health, gene drives and agriculture. There are numerous gene-editing tools besides CRISPR-Cas 9, which gets most of the attention because it is a comparatively easy tool to use.

Gene editing does not usually involve transgenics – moving ‘foreign’ genes between species. It also refers to a specific technique in contrast to the general term GMO, which is scientifically ambiguous, as genetic modification is a process not a product. Most gene editing involves creating new products by deleting very small segments of DNA (sometimes in agriculture called Site-Directed Nuclease 1 or SDN-1 techniques), which can silence a gene or change a gene’s activity. Countries are evaluating whether or not to regulate this type of gene editing, since it is so similar to natural mutations. The GLP’s Gene Editing Index ratings reflect the regulatory status of SDN-1 techniques, which are the most liberally regulated and will generate most products in the near term.

To develop different products, gene editing can change larger segments of DNA or add DNA from other species (a form of transgenics sometimes in agriculture called SDN-2 or SDN-3 techniques). While many countries are not regulating or lightly regulating SDN-1 techniques, most are moving toward tightly regulating or even restricting SDN-2 and SDN-3.

For more background on the various gene editing SDN techniques, read background articles here and here.